Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and ...
The neuromyelitis optica spectrum disorder market size in the 7MM is expected to show positive growth during the forecast period (2026--2036), mainly attributed to the increasing prevalence of NMOSD, ...
Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.
Faced with long waits and urgent needs, some Canadians are paying for care the health-care system already covers ...
The neuromyelitis optica spectrum disorder market size in the 7MM is expected to show positive growth during the forecast period (2026-2036), mainly attributed to the increasing prevalence of ...
Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming ...
Alpha Eta Phi, a sorority for women with multiple sclerosis, provides a supportive community, raises awareness, and empowers women to live fulfilling lives.
Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from DIAMOND Phase 3 trials with OCS-01 eye ...
The Hearty Soul on MSN
Doctors can spot diabetes and cancer in your eyes. Are you missing the signs?
The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...
SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with aquaporin-4 immunoglobulin ...
Inflammatory cells from a tattoo may breach the blood-ocular barrier, which is a wall-like structure designed to protect the ...
An increased risk for ischemic optic neuropathy may be associated with formulation- and dose-dependent GLP-1 receptor agonist use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results